Note: Ingredients listed on restricted chemical lists
EC/CAS
215-185-5/1310-73-2
Name of the chemical
sodium hydroxide
Concentration
0.5%< >=5% <5% 0.5%<
EC/CAS
231-595-7/7647-01-0
Name of the chemical
Hydrochloric acid
Concentration
<25% 017-002- >=25% <25% >=10%
EC/CAS
231-791-2/7732-18-5
Name of the chemical
Water, distilled, conductivity or of similar purity H2O
Concentration
10%<=C<25%
EC/CAS
231-598-3/25322-68-3
Name of the chemical
polyethyleneglycol
Concentration
*
EC/CAS
500-019-9/9003-39-8
Name of the chemical
polyvinylpyrrolidone
Concentration
*
EC/CAS
500-019-9/9005-65-6
Name of the chemical
polyethyleneglycol sorbitan monooleate
Concentration
0.05-0.1
EC/CAS
202-785-7/99-76-3
Name of the chemical
4-hydroxybenzoic acid, methyl ester
Concentration
N/A
EC/CAS
94-13-3
Name of the chemical
Propylparaben; propyl 4-hydroxybenzoate
Concentration
N/A
EC/CAS
202-307-7
Name of the chemical
Propylparaben; propyl 4-hydroxybenzoate
Concentration
0.01-0.1
General Information
Version
9
Revision date
2025-08-01
Product name
Medroxyprogesterone Acetate Suspension - Uniject
Product name
Medroxyprogesterone Acetate Suspension - Uniject
Identification on the label/Trade name
DEPO-PROVERA; SAYANA
Product Synonyms
Medroxyprogesterone Suspension for Injection, Subcutaneous; DEPO-SUBQ PROVERA; Medroxyprogesterone Suspension for Injection, Subcutaneous; DEPO-SUBQ PROVERA; depo-subQ provera 104
Chemical name
Mixture
1.2.1 Relevant identified uses
Pharmaceutical product used as contraceptive agent
Icons in SDS
Company Information
company name
Pfizer Inc
e-mail address of the competent person responsible for the Safety Data Sheet
pfizer-MSDS@pfizer.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H351, H360FD, H402, H412
Hazard statements
Code
Statements
H351
Suspected of causing cancer
Section 2
SECTION 2: Hazards identification
OSHA Classification of the substance or mixture
2.3 Other hazards
Not applicable (HNOC) An Occupational Exposure Value has been established for one or more of the ingredients (see Section 8).
Signal word
Danger
Hazard statements
H351 - Suspected of causing cancer H360FD - May damage fertility. May damage the unborn child EUH380 - May cause endocrine disruption in humans H412 - Harmful to aquatic life with long lasting effects EUH430 - May cause endocrine disruption in the environment
Precautionary statements
P201 - Obtain special instructions before use P202 - Do not handle until all safety precautions have been read and understood P263 - Avoid contact during pregnancy/while nursing P273 - Avoid release to the environment P280 - Wear protective gloves, protective clothing, eye protection and face protection P308 + P313 - IF exposed or concerned: Get medical advice/attention P391 - Collect spillage P405 - Store locked up P501 - Dispose of contents/container in accordance with local, regional, national, and international regulations as applicable Unknown acute toxicity 16 % of the mixture consists of ingredient(s) of unknown acute dermal toxicity. 16 % of the mixture consists of ingredient(s) of unknown acute inhalation toxicity (dust/mist).
PBT Substances
& vPvB The product does not contain any substance(s) classified as PBT or vPvB. Endocrine Disruptor Information Chemical name Contains a known or suspected endocrine disruptor.
2.1 Classification of the substance or mixture
GHS - Classification. Regulated according to Regulation (EC) 1272/2008 and/or other applicable regulations. Carcinogenicity Category 2 - (H351) Reproductive toxicity Category 1A - (H360FD) Endocrine disruption for human health Category 1 - (EUH380) Hazardous to the aquatic environment - acute Category 3 - (H402) Hazardous to the aquatic environment - chronic Category 3 - (H412) Endocrine disruption for the environment Category 1 - (EUH430) OSHA Classification Hazards not otherwise classified (HNOC) Not applicable Hazards classified under paragraph (d)(1)(ii) of 1910.1200 Not applicable
